Category Human Rights

Brazil Approval Of Embryonic Stem Cell Research Could Boost Patenting

By Claudia Jurberg for Intellectual Property Watch RIO DE JANEIRO – After three days of consideration, the Brazilian Supreme Court last week approved by a narrow 6 to 5 margin research involving embryonic stem cells. The 29 May vote followed…

ACAC : négociations houleuses cette semaine à Genève – les États-Unis envisagent une ratification cette année

Monika Ermert pour Intellectual Property Watch Selon un représentant de la Commission européenne, des négociations formelles sur l’Accord commercial anti-contrefaçon (ACAC) commencent cette semaine à Genève, et ce malgré la parution d’un document ayant filtré d’un bureau commercial américain et…

“Great Achievement” On IP Issues At Convention On Biological Diversity Summit

By Kaitlin Mara Government negotiators meeting in Bonn this week reached breakthroughs on two intellectual property-related areas of the United Nations Convention on Biological Diversity (CBD). At the highest level of the CBD membership, agreement was struck on a way…

L’OMS adopte le document le plus important depuis Doha en matière de propriété intellectuelle et de santé publique

William New Avec la stratégie mondiale adoptée samedi lors de l’Assemblée mondiale de la Santé en vue de combler le vide en matière de recherche sur les maladies qui sévissent dans les pays en développement, l’institution des Nations Unies s’inscrit…

WHO Adopts “Most Important Document Since Doha” On IP And Public Health

By William New The annual World Health Assembly on Saturday adopted a global strategy aimed at filling the research gap for diseases afflicting developing countries that places the UN agency squarely in global intellectual property policymaking and despite compromises is…

WHO Members Near Accord On Global Strategy On IP And Health

By William New Down to the final hours before the closing ceremonies of this year’s World Health Assembly, governments have nearly completed work on a global strategy to stimulate research into neglected diseases disproportionately affecting poor populations. But work skipped…